{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "multifunctional agents", "naringenin-O-alkylamine derivatives", "scopolamine-induced mice memory impairment"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35193434", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/14756366.2022.2041627"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "37", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Development of naringenin-<i>O</i>-alkylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease.", "Pagination": {"StartPage": "792", "EndPage": "816", "MedlinePgn": "792-816"}, "Abstract": {"AbstractText": ["In this study, a series of naringenin-<i>O</i>-alkylamine derivatives were designed and obtained by introducing an alkylamine fragment into the naringenin skeleton. The <i>in\u00a0vitro</i> biological activity results revealed that compounds <b>5f</b> and <b>7k</b> showed good antioxidant activity with ORAC values of 2.3<i>eq</i> and 1.2<i>eq</i>, respectively. Compounds <b>5f</b> and <b>7k</b> were reversible and excellent <i>hu</i>AChE inhibitors with IC<sub>50</sub> values of 0.91\u2009\u03bcM and 0.57\u2009\u03bcM, respectively. Moreover, compounds <b>5f</b> and <b>7k</b> could inhibit self-induced A<i>\u03b2</i><sub>1-42</sub> aggregation with 62.1% and 43.8% inhibition rate, respectively, and significantly inhibited <i>hu</i>AChE-A<i>\u03b2</i><sub>1-40</sub> aggregation with 51.7% and 43.4% inhibition rate, respectively. In addition, compounds <b>5f</b> and <b>7k</b> were selective metal chelators and remarkably inhibited Cu<sup>2+</sup>-induced A<i>\u03b2</i><sub>1-42</sub> aggregation with 73.5% and 68.7% inhibition rates, respectively. Furthermore, compounds <b>5f</b> and <b>7k</b> could cross <b>the</b> blood-brain barrier <i>in\u00a0vitro</i> and displayed good neuroprotective effects and anti-inflammatory properties. Further investigation showed that compound <b>5f</b> did not show obvious hepatotoxicity and displayed a good hepatoprotective effect by its antioxidant activity. The <i>in\u00a0vivo</i> study displayed that compound <b>5f</b> significantly improved scopolamine-induced mice memory impairment. Therefore, compound <b>5f</b> was a potential multifunctional candidate for the treatment of AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, China."}], "LastName": "Yang", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, China."}], "LastName": "Zhou", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}], "LastName": "Ban", "ForeName": "Yujuan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, China."}], "LastName": "Mi", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, China."}], "LastName": "He", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, China."}], "LastName": "Li", "ForeName": "Xinjuan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, China."}], "LastName": "Liu", "ForeName": "Zhengwei", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, China."}], "LastName": "Wang", "ForeName": "Keren", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhu", "ForeName": "Gaofeng", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, China."}], "LastName": "Liu", "ForeName": "Wenmin", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Traditional Chinese Medicine Pharmacology and Toxicology, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China."}], "LastName": "Tan", "ForeName": "Zhenghuai", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}], "LastName": "Sang", "ForeName": "Zhipei", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amines"}, {"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavanones"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Aggregates"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}, {"RegistryNumber": "HN5425SBF2", "NameOfSubstance": "naringenin"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Amines"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Blood-Brain Barrier"}, {"QualifierName": ["metabolism"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Development"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Flavanones"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Protein Aggregates"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "World Alzheimer Report 2019: Attitudes to Dementia, Alzheimer\u2019s Disease International; 2019, pp. 1\u201313."}, {"Citation": "Jagust W. Imaging the evolution and pathophysiology of Alzheimer disease. Nat Rev Neurosci 2018;19:687\u2013700.", "ArticleIdList": ["PMC7032048", "30266970"]}, {"Citation": "Anand P, Singh B.. A review on cholinesterase inhibitors for Alzheimer's disease. Arch Pharm Res 2013;36:375\u201399.", "ArticleIdList": ["23435942"]}, {"Citation": "Hebscher M, Voss JL.. Testing network properties of episodic memory using non-invasive brain stimulation. Curr Opin Behav Sci 2020;32:35\u201342.", "ArticleIdList": ["PMC7138212", "32266318"]}, {"Citation": "Alvarez A, Opazo C, Alarc\u00f3n R, et al. . Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. J Mol Biol 1997;272:348\u201361.", "ArticleIdList": ["9325095"]}, {"Citation": "Hardy J, Selkoe DJ.. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297: 353\u20136.", "ArticleIdList": ["12130773"]}, {"Citation": "Calsolaro V, Edison P.. Neuroinflammation in Alzheimer's disease: current evidence and future\u00a0directions. Alzheimers Dement 2016;12:719\u201332.", "ArticleIdList": ["27179961"]}, {"Citation": "Cheignon C, Tomas M, Bonnefont-Rousselot D, et al. . Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol 2018;14:450\u201364.", "ArticleIdList": ["PMC5680523", "29080524"]}, {"Citation": "Lane DJR, Ayton S, Bush AI.. Iron and Alzheimer's disease: an update on emerging mechanisms. J Alzheimers Dis 2018;64:S379\u2013S395.", "ArticleIdList": ["29865061"]}, {"Citation": "Cavalli A, Bolognesi ML, Minarini A, et al. . Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 2008;51:347\u201372.", "ArticleIdList": ["18181565"]}, {"Citation": "Zhang P, Xu S, Zhu Z, Xu J.. Multi-target design strategies for the improved treatment of Alzheimer's disease. Eur J Med Chem 2019;176:228\u201347.", "ArticleIdList": ["31103902"]}, {"Citation": "de Freitas Silva M, Dias KST, Gontijo VS, et al. . Multi-target directed drugs as a modern approach for drug design towards Alzheimer's disease: an update. Curr Med Chem 2018;25:3491\u2013525.", "ArticleIdList": ["29332563"]}, {"Citation": "Huang W, Liang M, Li Q, et al. . Development of the \"hidden\" multifunctional agents for Alzheimer's disease. Eur J Med Chem 2019;177:247\u201358.", "ArticleIdList": ["31158742"]}, {"Citation": "Joshi R, Kulkarni YA, Wairkar S.. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: an update. Life Sci 2018;215:43\u201356.", "ArticleIdList": ["30391464"]}, {"Citation": "Ghofrani S, Joghataei MT, Mohseni S, et al. . Naringenin improves learning and memory in an Alzheimer's disease rat model: insights into the underlying mechanisms. Eur J Pharmacol 2015;764:195\u2013201.", "ArticleIdList": ["26148826"]}, {"Citation": "Wu J, Kou X, Ju H, et al. . Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. Bioorg Med Chem Lett 2021;49:128316.", "ArticleIdList": ["34391893"]}, {"Citation": "Sang Z, Qiang X, Li Y, et al. . Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem 2015;94:348\u201366.", "ArticleIdList": ["25778991"]}, {"Citation": "Bai P, Wang K, Zhang P, et al. . Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease. Eur J Med Chem 2019;183:111737.", "ArticleIdList": ["31581002"]}, {"Citation": "Qiang X, Sang Z, Yuan W, et al. . Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem 2014;76:314\u201331.", "ArticleIdList": ["24589487"]}, {"Citation": "Sang Z, Wang K, Shi J, et al. . The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease. Eur J Med Chem 2020;192:112180.", "ArticleIdList": ["32131034"]}, {"Citation": "Li HQ, Shi L, Li QS, Liu PG, et al. . Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics. Bioorg Med Chem 2009;17:6264\u20139.", "ArticleIdList": ["19664929"]}, {"Citation": "Sang Z, Wang K, Shi J, et al. . Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease. Eur J Med Chem 2020;187:111958.", "ArticleIdList": ["31865014"]}, {"Citation": "Ko\u0161ak U, Brus B, Knez D, et al. . The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in\u00a0vivo activity. J Med Chem 2018;61:119\u201339.", "ArticleIdList": ["29227101"]}, {"Citation": "Wang LL, Du Y, Li SM, et al. . Design, synthesis and evaluation of tetrahydrocarbazole derivatives as potential hypoglycemic agents. Bioorg Chem 2021;115:105172.", "ArticleIdList": ["34303898"]}, {"Citation": "Sharma P, Tripathi A, Tripathi PN, et al. . Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease. Eur J Med Chem 2019;167:510\u201324.", "ArticleIdList": ["30784883"]}, {"Citation": "Tripathi A, Choubey PK, Sharma P, et al. . Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease. Eur J Med Chem 2019;183:111707.", "ArticleIdList": ["31561043"]}, {"Citation": "Tripathi PN, Srivastava P, Sharma P, et al. . Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. Bioorg Chem 2019;85:82\u201396.", "ArticleIdList": ["30605887"]}, {"Citation": "Sang Z, Wang K, Han X, et al. . Design, synthesis, and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease. ACS Chem Neurosci 2019;10:1008\u201324.", "ArticleIdList": ["30537804"]}, {"Citation": "Li Y, Qiang X, Li Y, et al. . Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-\u03b2-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease. Bioorg Med Chem Lett 2016;26:2035\u20139.", "ArticleIdList": ["26947607"]}, {"Citation": "Di L, Kerns EH, Fan K, et al. . High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem 2003;38:223\u201332.", "ArticleIdList": ["12667689"]}, {"Citation": "Sang Z, Wang K, Bai P, et al. . Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease. Eur J Med Chem 2020;194:112265.", "ArticleIdList": ["32240904"]}, {"Citation": "Tian C, Qiang X, Song Q, et al. . Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: design, synthesis and biological evaluation. Bioorg Chem 2020;94:103477.", "ArticleIdList": ["31818478"]}, {"Citation": "Yang Z, Song Q, Cao Z, et al. . Design, synthesis and evaluation of flurbiprofen-clioquinol hybrids as multitarget-directed ligands against Alzheimer's disease. Bioorg Med Chem 2020;28:115374.", "ArticleIdList": ["32089390"]}, {"Citation": "http://www.molinspiration.com/cgi-bin/properties"}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "23", "Hour": "5", "Minute": "28"}, {"Year": "2022", "Month": "2", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "22"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35193434", "PMC8881077", "10.1080/14756366.2022.2041627"]}}], "PubmedBookArticle": []}